Study for the effectiveness of intensive therapy for diabetic nephropathy in unblinded, randomized intergroup comparison study. - Study for the effectiveness of intensive therapy aiming at a remission of diabetic nephropathy (DNETT-Japan)

Okayama University Hospital0 sites600 target enrollmentNovember 16, 2005

Overview

No summary available.

Registry

who.int

Start Date

November 16, 2005

End Date

June 1, 2011

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•Patients who fall into the following categories are not eligible:1\) Patients with type 1 diabetes mellitus2\) Patients with hereditary diabetes mellitus or secondary diabetes mellitus.3\) Patients with non\-diabetic nephropathy, e.g., glomerular nephritis, lupus nephritis.4\) Patients with familial hypercholesterolemia.5\) Patients with secondary hypertension.6\) Patients with unstable angina pectoris, or patients who have developed myocardial infarction or cerebral hemorrhage within 6 months prior to the observation period.7\) Patients with any life\-threatening disease which will be the cause of death within five years such as malignant tumor.8\) Patients with a history of angio edema.9\) Patients under LDL\-apheresis by a adsorber with dextran sulphate cellose.10\) Patients with biliary obstruction or severe hepatopathy.11\) Patients considered as having hypergasia of hepatic metabolism such as acute hepatitis, acute exacerbation of chronic hepatitis, cirrhosis, hepatic cancer, or jaundice.12\) Patients with a history of hypersensitivity against ACE inhibitors, ARBs, or HMG\-CoA reductase inhibitors.13\) 0patiens, and patients who want to become pregnant during the study period.14\) Other patients judged as being inappropriate for the subjects of the study by investigators.